Oral gefitinib plus methotrexate is not clinically superior to methotrexate for tubal ectopic pregnancy.

Published Date: 17 Feb 2023

A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...

Read Full News

Latest News

Free Contraception Coverage Curbs Patients’ Costs in BC

Universal contraceptive coverage reduces out-of-pocket costs substantially in British Columbia, especially for young people.

Upcoming Billing Change Could Make Pregnancy Pricier

Under new billing codes starting in January, maternity care doctors will charge à la carte for visits and services related to pregnancy, childbirth, and postpartum care.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

J&J Beats Lawsuit Alleging That Talc Caused Three Women's Cancer

A Los Angeles jury on Friday sided with ⁠Johnson & Johnson in a lawsuit by the families of three women who alleged ⁠that the company's talc products caused ovarian...

FDA Launches Study Of Abortion Pill Safety, WSJ Reports

(Fixes typo in paragraph 6)

Wearable Ultrasound Patch Does Continuous Fetal Monitoring

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Todays Updates

Inside the Major Findings From the NHS-Galleri Trial

The largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.

Talquetamab Combos Show Survival Benefit in r/r Myeloma

Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.

Latest News

Universal contraceptive coverage reduces out-of-pocket costs substantially in British Columbia, especially for young people.

Under new billing codes starting in January, maternity care doctors will charge à la carte for visits and services related to pregnancy, childbirth, and postpartum care.

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

A Los Angeles jury on Friday sided with ⁠Johnson & Johnson in a lawsuit by the families of three women who alleged ⁠that the company's talc products caused ovarian...

(Fixes typo in paragraph 6)

A skin-mounted ultrasound patch tracks fetal blood flow in real time and may help detect complications in high-risk pregnancies earlier than intermittent scans.

News All Time

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Emerging Evidence and Expert Perspectives: Evolving Treatment Strategies in HER2+ Early Breast Cancer

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Scaling Excellence in HER2-Low and -Ultralow Breast Cancer: Real-World Strategies for Testing and Treatment Optimization

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Facing Resistance: Novel Approaches for Endocrine-Resistant HR+/HER2- Breast Cancer

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Beyond CLEOPATRA: Integrating Evolving Frontline Maintenance Strategies in HER2+ Metastatic Breast Cancer

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Powering Up First-Line Treatment in Triple-Negative Breast Cancer: How Antibody-Drug Conjugates and Immune Checkpoint Inhibitors Are Changing the Game

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

Platinum-Resistant Ovarian Cancer (PROC) Office Hours: Translating Clinical Trials Into Clinical Practice for PROC

ACOG: American College of Obstetricians and Gynecologists

ASRM: American Society for Reproductive Medicine

SMFM: Society for Maternal-Fetal Medicine

SGO: Society of Gynecologic Oncology

TMS: The Menopause Society

Former UCLA Gynecologist Pleads Guilty to Sex Abuse After Conviction Was Overturned

The plea was unexpected

HHS Changing Its Tune on Contraceptive Access

Focus of Title X program shifting to "natural family planning" and encouragement of pregnancy

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents

Also from SGO: p53 reactivator active in advanced gynecologic cancers, "perfect" score in GTN

DOJ Fires Prosecutors Accused of Bias Against Anti-Abortion Activists

They are the latest wave of terminations of those involved in cases criticized by conservatives

'Something Is Wrong': Don't Dismiss Pregnant Patients

Bias often shapes whose voices we prioritize and whose we question

Recommended News For You

New protein target discovered for childhood medulloblastomas

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

Liver cancer survival rates reflect income disparities

Clinical trial could lead to new 'gold standard' test for prostate cancer detection

Can MRI Curb Chemo Overtreatment in Breast Cancer?

Asymptomatic or Minimally Symptomatic Myelofibrosis

Is Laughter Good for Blood Glucose Control?

Recommended Articles For You

A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era 

Comprehensive Techniques in Hematology in Clinical Decision-Making 

Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis 

Immuno-Oncology in Daily Practice: Transforming Cancer Care One Patient at a Time 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL

2.

Is Exercise an Effective Treatment for Prostate Cancer?

3.

Which Risk Model Better Identifies High-Risk Smoldering MM?

4.

Spouses of Cancer Patients May Be at Increased Risk of Suicide

5.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

1.

Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment

2.

Beyond the Battle: Navigating Life After Cancer

3.

The Impact of Microadenoma on Hormonal Health

4.

Exploring the Role of Fecal Leukocytes in Intestinal Health

5.

Oncological Surgery Today: Personalized, Interdisciplinary Approaches to Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma

3.

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

5.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot